ArticleScientific reports2025
MCC950 targets the ROS-NEK7-NLRP3 axis to improve type 2 diabetic retinopathy.
Kexuan Ren et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleScientific reports2025
Kexuan Ren et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.